Abeona Therapeutics Inc.
US ˙ NasdaqCM ˙ US00289Y2063

Introduction

This page provides a comprehensive analysis of the known insider trading history of Steven H Rouhandeh. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Steven H Rouhandeh has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ABEO / Abeona Therapeutics Inc. Director, 10% Owner 49,084
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Steven H Rouhandeh. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ABEO / Abeona Therapeutics Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ABEO / Abeona Therapeutics Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2014-12-24 PTBI Rouhandeh Steven H 250,000 4.0000 10,000 100.0000 1,000,000 731 4.8000 -952,000 -95.20

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ABEO / Abeona Therapeutics Inc. Insider Trades
Insider Sales ABEO / Abeona Therapeutics Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ABEO / Abeona Therapeutics Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2020-09-15 ABEO SCO CAPITAL PARTNERS LLC 1,989 2.0017 80 50.0425 3,981 15 1.0200 -3,900 -97.98
2020-09-11 ABEO SCO CAPITAL PARTNERS LLC 4,600 2.0095 184 50.2375 9,244
2020-09-10 ABEO SCO CAPITAL PARTNERS LLC 73,411 2.0771 2,936 51.9275 152,482
2020-08-17 ABEO SCO CAPITAL PARTNERS LLC 80,000 2.8539 3,200 71.3475 228,312

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ABEO / Abeona Therapeutics Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Steven H Rouhandeh as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2021-05-27 2021-05-25 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 49,084 49,084
2021-05-27 2021-05-25 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
A - Award 38,590 533,590 7.80
2021-05-05 2021-05-03 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale X -80,000 11,079,292 -0.72 2.01 -160,888 22,281,564
2021-03-19 2021-03-18 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale X -80,000 11,159,292 -0.71 2.23 -178,624 24,916,467
2021-02-18 2021-02-16 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale X -120,000 11,239,292 -1.06 2.97 -356,808 33,418,911
2021-02-10 2021-02-08 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale X -240,000 11,359,292 -2.07 3.01 -722,832 34,211,916
2021-01-19 2021-01-19 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale X -207,117 11,599,292 -1.75 2.08 -431,218 24,149,726
2021-01-19 2021-01-15 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale X -81,283 11,806,409 -0.68 2.02 -164,086 23,833,598
2021-01-19 2021-01-14 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale X -31,600 11,887,692 -0.27 2.00 -63,213 23,780,139
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -80,000 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 80,000 80,000
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -125,000 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 125,000 125,000
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -200,000 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -200,000 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 200,000 200,000
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 200,000 200,000
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -120,000 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -120,000 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 120,000 120,000
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 120,000 120,000
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -153,244 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 153,244 153,244
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
D - Sale to Issuer -86,756 0 -100.00
2020-11-20 2020-11-20 4 ABEO ABEONA THERAPEUTICS INC.
Stock Option (right to buy)
A - Award 86,756 86,756
2020-09-17 2020-09-15 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale -1,989 11,919,292 -0.02 2.00 -3,981 23,858,847
2020-09-14 2020-09-11 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale -4,600 11,921,281 -0.04 2.01 -9,244 23,955,814
2020-09-14 2020-09-10 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale -73,411 11,925,881 -0.61 2.08 -152,482 24,771,247
2020-08-19 2020-08-17 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
S - Sale -80,000 11,999,292 -0.66 2.85 -228,312 34,244,779
2020-05-22 2020-05-20 4 ABEO ABEONA THERAPEUTICS INC.
Employee Stock Option (right to buy)
A - Award 86,756 86,756
2020-05-22 2020-05-20 4 ABEO ABEONA THERAPEUTICS INC.
Common Stock
A - Award 120,000 495,000 32.00
2020-03-18 2020-03-16 4 ABEO ABEONA THERAPEUTICS INC.
Employee Stock Option (right to buy)
A - Award 153,244 153,244
2019-04-11 2019-04-09 4 ABEO ABEONA THERAPEUTICS INC.
Employee Stock Option (right to buy)
A - Award 120,000 120,000
2017-12-18 2017-12-14 4 ABEO ABEONA THERAPEUTICS INC.
Stock option (right to buy)
A - Award 90,000 90,000
2017-12-18 2017-12-14 4 ABEO ABEONA THERAPEUTICS INC.
Srock option (right to buy)
A - Award 30,000 30,000
2016-12-15 2016-12-13 4 ABEO ABEONA THERAPEUTICS INC.
Stock option (right to buy)
A - Award 150,000 200,000 300.00
2016-12-15 2016-12-13 4 ABEO ABEONA THERAPEUTICS INC.
Stock option (right to buy)
A - Award 50,000 50,000
2016-02-16 2016-02-11 4 ABEO ABEONA THERAPEUTICS INC.
Stock option (right to buy)
A - Award 150,000 200,000 300.00
2016-02-16 2016-02-11 4 ABEO ABEONA THERAPEUTICS INC.
Stock option (right to buy)
A - Award 50,000 50,000
2015-06-19 2015-05-11 4/A ABEO ABEONA THERAPEUTICS INC.
Stock option (right to buy)
A - Award 125,000 125,000
2015-06-19 2015-05-11 4/A ABEO ABEONA THERAPEUTICS INC.
Common stock
A - Award 375,000 375,000
2015-05-13 2015-05-11 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Stock option (right to buy)
A - Award 125,000 205,000 156.25 7.34 917,500 1,504,700
2015-05-13 2015-05-11 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common stock
A - Award 375,000 375,000 7.34 2,752,500 2,752,500
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series B Cumlative Convertible Preferred Stock
J - Other -139 0 -100.00 4.00 -554
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series B Cumulative Convertible Preferred Stock
J - Other -861 0 -100.00 4.00 -3,446
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series A Cumulative Convertible Preferred Stock
C - Conversion -154 0 -100.00 4.00 -617
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series A Cumlative Convertible Preferred Stock
C - Conversion -1,969 0 -100.00 4.00 -7,875
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock Purchase Warrants
P - Purchase 250,000 250,000 0.01 2,500 2,500
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 216,718 1,364,195 18.89 4.00 866,872 5,456,780
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 1,703,362 12,079,291 16.42 4.00 6,813,448 48,317,164
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 693,051 1,147,477 152.51 4.00 2,772,204 4,589,908
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 4,306,950 10,375,930 70.97 4.00 17,227,800 41,503,720
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 65,280 454,427 16.78 4.00 261,120 1,817,708
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 831,836 6,068,980 15.88 4.00 3,327,344 24,275,920
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 385,725 389,147 11,271.92 4.00 1,542,900 1,556,588
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 4,922,102 5,237,144 1,562.36 4.00 19,688,408 20,948,576
2014-12-30 2014-12-24 4/A PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 250,000 315,042 384.37 4.00 1,000,000 1,260,168
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series B Cumulative Convertible Preferred Stock
J - Other -139 0 -100.00 4.00 -554
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series B Cumulative Convertible Preferred Stock
J - Other -861 0 -100.00 4.00 -3,446
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series A Cumulative Convertible Preferred Stock
C - Conversion -154 0 -100.00 4.00 -617
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Series A Cumulative Convertible Preferred Stock
C - Conversion -1,969 0 -100.00 4.00 -7,875
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock Purchase Warrants
P - Purchase 250,000 702,195 55.29 0.01 2,500 7,022
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 216,718 1,364,195 18.89 4.00 866,872 5,456,780
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 1,703,362 12,080,463 16.41 4.00 6,813,448 48,321,852
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 693,051 1,147,477 152.51 4.00 2,772,204 4,589,908
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
J - Other 4,306,950 10,377,102 70.95 4.00 17,227,800 41,508,408
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 65,280 454,427 16.78 4.00 261,120 1,817,708
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 831,836 6,070,152 15.88 4.00 3,327,344 24,280,608
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 385,725 389,147 11,271.92 4.00 1,542,900 1,556,588
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 4,922,102 5,238,316 1,556.57 4.00 19,688,408 20,953,264
2014-12-29 2014-12-24 4 PTBI PLASMATECH BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 250,000 316,214 377.56 4.00 1,000,000 1,264,856
2014-03-11 2014-03-07 4 accp ACCESS PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 3,000,000 4,000,000 300.00 0.37 1,110,000 1,480,000
2014-03-11 2014-03-07 4 accp ACCESS PHARMACEUTICALS INC
Stock option (right to buy)
A - Award 1,000,000 1,000,000 0.37 370,000 370,000
2012-12-20 2012-12-19 4 accp ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants
G - Gift 1,366,202 2,772,202 97.17
2012-12-20 2012-12-19 4 accp ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants
G - Gift -1,366,202 17,227,798 -7.35
2012-12-20 2012-12-19 4 accp ACCESS PHARMACEUTICALS INC
Series B Cumulative Convertible Preferred Stock
G - Gift 68 139 97.17 10,000.00 683,101 1,386,101
2012-12-20 2012-12-19 4 accp ACCESS PHARMACEUTICALS INC
Series B Cumulative Convertible Preferred Stock
G - Gift -68 861 -7.35 10,000.00 -683,101 8,613,899
2012-10-26 2012-10-25 4 accp ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants
P - Purchase 1,406,000 1,406,000
2012-10-26 2012-10-25 4 accp ACCESS PHARMACEUTICALS INC
Common Stock Purchase Warrants
P - Purchase 18,594,000 18,594,000
2012-10-26 2012-10-25 4 accp ACCESS PHARMACEUTICALS INC
Series B Cumulative Convertible Preferred Stock
P - Purchase 70 70 10,000.00 703,000 703,000
2012-10-26 2012-10-25 4 accp ACCESS PHARMACEUTICALS INC
Series B Cumulative Convertible Preferred Stock
P - Purchase 930 930 10,000.00 9,297,000 9,297,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)